Cargando…

Immune Response and Effects of COVID-19 Vaccination in Patients with Lung Cancer—COVID Lung Vaccine Study

SIMPLE SUMMARY: During the SARS-CoV-2 pandemic, lung cancer patients have been considered an especially vulnerable population and have been prioritized for vaccination. However, several aspects (degree of immunity, potential interaction with active anticancer therapy, safety, and tolerability of the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hernandez, Ainhoa, Boigues, Marc, Felip, Eudald, Cucurull, Marc, Notario, Lucia, Pous, Anna, Torres, Pere, Benitez, Marta, Rodriguez, Marina, Quirant, Bibiana, Romeo, Margarita, Fuster, Daniel, Moran, Teresa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9817972/ https://www.ncbi.nlm.nih.gov/pubmed/36612134 http://dx.doi.org/10.3390/cancers15010137

Ejemplares similares

OA06.04 Immune Response after SARS-CoV-2 Vaccination in Lung Cancer Patients. Update of the Covid Lung Vaccine Cohort
por: Hernandez, A., et al.
Publicado: (2022)

1591P Immune response after vaccination against SARS-COV-2 in lung cancer (LC) patients (p). Prospective study in the Medical Oncology Department at the Catalan Institute of Oncology-Badalona, Spain: COVID-lung vaccine
por: Felip, E., et al.
Publicado: (2021)

Impact of chemotherapy and/or immunotherapy on neutralizing antibody response to SARS‐CoV‐2 mRNA‐1237 vaccine in patients with solid tumors
por: Felip, Eudald, et al.
Publicado: (2022)

Immune-checkpoint inhibitors for lung cancer patients amid the COVID-19 pandemic: a case report of severe meningoencephalitis after switching to an extended-interval higher flat-dose nivolumab regimen
por: Pous, Anna, et al.
Publicado: (2021)

Small-Cell Lung Cancer Long-Term Survivor Patients: How to Find a Needle in a Haystack?
por: Plaja, Andrea, et al.
Publicado: (2021)

Characterization of a cohort of metastatic lung cancer patients harboring KRAS mutations treated with immunotherapy: differences according to KRAS G12C vs. non-G12C
por: Notario, Lucía, et al.
Publicado: (2023)

Targeting KRAS in Lung Cancer Beyond KRAS G12C Inhibitors: The Immune Regulatory Role of KRAS and Novel Therapeutic Strategies
por: Cucurull, Marc, et al.
Publicado: (2022)

SARS-CoV-2: una nueva amenaza
por: López Rodríguez, Cristina A., et al.
Publicado: (2020)

SARS-CoV-2: a new threat
por: López Rodríguez, Cristina A., et al.
Publicado: (2020)

Targeted Therapeutic Options and Future Perspectives for HER2-Positive Breast Cancer
por: Ferrando-Díez, Angelica, et al.
Publicado: (2022)

Real-world data on T-DM1 efficacy – results of a single-center retrospective study of HER2-positive breast cancer patients
por: Hardy-Werbin, Max, et al.
Publicado: (2019)

COVID-19 Vaccination in Lung Transplant Recipients
por: Altneu, Eric, et al.
Publicado: (2022)

COVID-19 vaccination and lung transplant recipients
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

The Interplay of Lung Cancer, COVID-19, and Vaccines
por: Trivanović, Dragan, et al.
Publicado: (2022)

Correlation between PD-L1 expression and MET gene amplification in patients with advanced non-small cell lung cancer and no other actionable oncogenic driver
por: Domènech, Marta, et al.
Publicado: (2021)

Follow up of the Humoral Response in Healthcare Workers after the Administration of Two Dose of the Anti SARS-CoV-2 Vaccines—Effectiveness in Delta Variant Breakthrough Infections
por: Fernández-Rivas, Gema, et al.
Publicado: (2022)

COVID-19 vaccine induced interstitial lung disease
por: Yoshifuji, Ayumi, et al.
Publicado: (2022)

1596P SERONCOVID: Seroconversion in solid-tumor cancer patients (p) after COVID-19 diagnosis
por: Pous, A., et al.
Publicado: (2021)

Heart–Lung–Muscle Anti-SAE Syndrome: An Atypical Severe Combination
por: Zamora, Elisabet, et al.
Publicado: (2018)

Vaccine Breakthrough Severe COVID-19 in a Lung Recipient
por: Beyoglu, Muhammet Ali, et al.
Publicado: (2022)

COVID-19 VACCINE UPTAKE IN AN INTERSTITIAL LUNG DISEASE CLINIC
por: LEAHY, AMY, et al.
Publicado: (2021)

COVID-19 vaccination immune paresis in heart and lung transplantation
por: Aslam, Saima, et al.
Publicado: (2021)

COVID-19 vaccine: Vaccine reaction, amyopathic dermatomyositis and interstitial lung disease: case report
Publicado: (2021)

HER2-Positive Gastric Cancer: The Role of Immunotherapy and Novel Therapeutic Strategies
por: Pous, Anna, et al.
Publicado: (2023)

Modulation of DNA Damage Response by SAM and HD Domain Containing Deoxynucleoside Triphosphate Triphosphohydrolase (SAMHD1) Determines Prognosis and Treatment Efficacy in Different Solid Tumor Types
por: Felip, Eudald, et al.
Publicado: (2022)

Impact of the COVID-19 Pandemic on Lung Function Laboratories: Considerations for “Today” and the “Day After”()
por: Burgos Rincón, Felip, et al.
Publicado: (2020)

Protocol for regional implementation of collaborative lung function testing
por: Vargas, Claudia, et al.
Publicado: (2016)

Monitoring EGFR-T790M mutation in serum/plasma for prediction of response to third-generation EGFR inhibitors in patients with lung cancer
por: Morán, Teresa, et al.
Publicado: (2018)

Kinetics of humoral immune response over 17 months of COVID-19 pandemic in a large cohort of healthcare workers in Spain: the ProHEpiC-19 study
por: Violán, Concepción, et al.
Publicado: (2022)

COVID-19 Vaccination is Associated With Favorable Outcomes Among Lung Transplant Patients With Breakthrough Infections
por: Bollineni, Srinivas, et al.
Publicado: (2022)

Correction: Monitoring EGFR-T790M mutation in serum/plasma for prediction of response to third-generation EGFR inhibitors in patients with lung cancer
por: Morán, Teresa, et al.
Publicado: (2019)

SAMHD1 expression modulates innate immune activation and correlates with ovarian cancer prognosis
por: Gutiérrez-Chamorro, Lucía, et al.
Publicado: (2023)

COVID-19 vaccination associated lung mass mimicking a primary lung cancer: a novel manifestation
por: Ostler, Alexandra, et al.
Publicado: (2022)

Promising lung cancer vaccine.
Publicado: (1996)

Increased Natural Killer Cells Are Associated with Alcohol Liver Fibrosis and with T Cell and Cytotoxic Subpopulations Change
por: Zuluaga, Paola, et al.
Publicado: (2022)

Vaccine Therapy in Non-Small Cell Lung Cancer
por: García-Pardo, Miguel, et al.
Publicado: (2022)

(700) Vaccination with >2 Doses of Mrna Vaccines is Needed to Reduce Mortality Among Lung Transplant Recipients with Covid-19
por: Sindu, D., et al.
Publicado: (2023)

Differences in clinical characteristics and quantitative lung CT features between vaccinated and not vaccinated hospitalized COVID-19 patients in Italy
por: Chiumello, Davide, et al.
Publicado: (2023)

Alopecia Areata after COVID-19 Vaccines
por: Genco, Lucia, et al.
Publicado: (2023)

Lung T cell response in COVID-19
por: Shakiba, Mehrnoush Hadaddzadeh, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_h6m4lifqem0kc0bakj3u2q5aiq